NasdaqGM - Nasdaq Real Time Price USD
Neuronetics, Inc. (STIM)
4.0100
-0.2800
(-6.53%)
At close: 4:00:00 PM EDT
3.9300
-0.08
(-2.00%)
After hours: 4:25:05 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 1,380,000 | 6 |
Sales | 369,708 | 11 |
Net Shares Purchased (Sold) | 1,010,292 | 17 |
Total Insider Shares Held | 5.85M | -- |
% Net Shares Purchased (Sold) | 20.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
FURLONG STEPHEN Chief Financial Officer | Sale at price 4.16 - 4.27 per share. | Direct | 853,281 | May 13, 2025 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 4.48 per share. | Direct | 1,689 | Mar 4, 2025 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 4.48 per share. | Direct | 8,364 | Mar 4, 2025 |
SULLIVAN KEITH J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
SULLIVAN KEITH J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
MACAN WILLIAM ANDREW General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
MACAN WILLIAM ANDREW General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
FURLONG STEPHEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
FURLONG STEPHEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 4.41 - 4.70 per share. | Direct | 229,237 | Feb 19, 2025 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 4.11 per share. | Direct | 77,946 | Feb 14, 2025 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 4.11 per share. | Direct | 71,132 | Feb 14, 2025 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 3.83 per share. | Direct | 46,630 | Feb 12, 2025 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 3.83 per share. | Direct | 41,536 | Feb 12, 2025 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 3.28 per share. | Direct | 134,454 | Feb 10, 2025 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 3.28 per share. | Direct | 6,462 | Feb 10, 2025 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 3.28 per share. | Direct | 48,662 | Feb 10, 2025 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 0.82 per share. | Direct | 1,264 | Oct 8, 2024 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 0.82 per share. | Direct | 1,122 | Oct 8, 2024 |
CASCELLA ROBERT A Director | Purchase at price 0.75 per share. | Direct | 75,000 | Sep 12, 2024 |
MUIR GLENN P Director | Purchase at price 0.80 per share. | Direct | 20,000 | Sep 5, 2024 |
MUIR GLENN P Director | Purchase at price 0.85 per share. | Direct | 21,250 | Aug 29, 2024 |
MUIR GLENN P Director | Purchase at price 1.00 per share. | Direct | 25,000 | Aug 20, 2024 |
CASCELLA ROBERT A Director | Purchase at price 1.06 - 1.14 per share. | Direct | 41,660 | Aug 19, 2024 |
CASCELLA ROBERT A Director | Purchase at price 0.79 - 0.88 per share. | Direct | 58,450 | Aug 15, 2024 |
MUIR GLENN P Director | Purchase at price 0.75 per share. | Direct | 18,878 | Aug 14, 2024 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 1.90 per share. | Direct | 45,908 | Jul 18, 2024 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 1.91 - 1.97 per share. | Direct | 46,087 | Jul 17, 2024 |
CASCELLA ROBERT A Director | Purchase at price 2.05 per share. | Direct | 102,550 | Jun 6, 2024 |
ROSENGARTEN MEGAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
MUIR GLENN P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
CASCELLA ROBERT A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
CONLEY SHERYL L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
MACAN WILLIAM ANDREW General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
FURLONG STEPHEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 2.94 - 3.16 per share. | Direct | 88,428 | Feb 29, 2024 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 3.16 - 3.33 per share. | Direct | 83,428 | Feb 28, 2024 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 3.30 per share. | Direct | 66,964 | Feb 26, 2024 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 3.23 per share. | Direct | 134,371 | Feb 23, 2024 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 2.96 per share. | Direct | 70,916 | Feb 20, 2024 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 3.38 per share. | Direct | 52,799 | Feb 14, 2024 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 3.51 per share. | Direct | 51,632 | Feb 9, 2024 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 3.39 per share. | Direct | 18,255 | Feb 6, 2024 |
FURLONG STEPHEN Chief Financial Officer | Sale at price 3.39 per share. | Direct | 19,706 | Feb 6, 2024 |
SULLIVAN KEITH J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 5, 2024 |
MACAN WILLIAM ANDREW General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 5, 2024 |
FURLONG STEPHEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 5, 2024 |
SULLIVAN KEITH J Chief Executive Officer | Sale at price 3.01 - 3.16 per share. | Direct | 60,210 | Jan 11, 2024 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 2.24 - 2.70 per share. | Direct | 87,011 | Dec 21, 2023 |
MACAN WILLIAM ANDREW General Counsel | Sale at price 1.16 per share. | Direct | 1,697 | Oct 6, 2023 |
Related Tickers
QTRX Quanterix Corporation
4.8100
-3.61%
BWAY BrainsWay Ltd.
10.40
-2.71%
APYX Apyx Medical Corporation
1.4800
-0.67%
CVRX CVRx, Inc.
6.26
-10.44%
NPCE NeuroPace, Inc.
18.13
+0.78%
RPID Rapid Micro Biosystems, Inc.
3.1600
-0.94%
LUNG Pulmonx Corporation
3.1400
-6.27%
OM Outset Medical, Inc.
18.60
-4.66%
CLPT ClearPoint Neuro, Inc.
12.16
-4.93%
SIBN SI-BONE, Inc.
19.12
-2.99%